Trials / Conditions / Pseudohypoparathyroidism Type 1a
Pseudohypoparathyroidism Type 1a
6 registered clinical trials studyying Pseudohypoparathyroidism Type 1a — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a) NCT07496463 | Massachusetts General Hospital | Phase 2 |
| Active Not Recruiting | Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old NCT04551170 | Vanderbilt University Medical Center | Phase 2 |
| Enrolling By Invitation | Theophylline for Treatment of Pseudohypoparathyroidism NCT04240821 | Ashley Shoemaker | Phase 2 |
| Completed | Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystr NCT02463409 | Vanderbilt University Medical Center | Phase 2 |
| Terminated | Energy Expenditure and Body Composition in Pseudohypoparathyroidism 1a NCT01398774 | Children's Hospital of Philadelphia | — |
| Recruiting | Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments NCT00209235 | Connecticut Children's Medical Center | N/A |